• linkedin
  • Increase Font
  • Sharebar

    The 5 Latest FDA Drug Approvals

    The FDA has already approved 24 new drugs in 2017.



    BEVYXXA (betrixaban), Portola Pharma

    Indications: Prophylaxis of venous thromboembolism (VTE) in adult patients.

    Dosage: An initial single dose of 160 mg, followed by 80 mg once daily, taken at the same time each day with food.

    Contraindications: Active pathological bleeding, severe hypersensitivity reaction to betrixaban.

    Read the full label here

    Previous ButtonNext Button



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available